| DAPAGLIFLOZIN AND SAXAGLIPTIN |
211533 |
001 |
ANDA |
DAPAGLIFLOZIN; SAXAGLIPTIN |
TABLET; ORAL |
10MG/5MG |
No
|
No
|
2020/05/28
(TA)
|
--
|
MSN LABS PVT LTD |
None (Tentative Approval) |
| DAPAGLIFLOZIN AND SAXAGLIPTIN MONOHYDRATE |
211532 |
001 |
ANDA |
DAPAGLIFLOZIN, SAXAGLIPTIN MONOHYDRATE |
TABLET; ORAL |
5MG |
No
|
No
|
2024/01/03
(TA)
|
--
|
LUPIN LTD |
None (Tentative Approval) |
| DAPAGLIFLOZIN AND SAXAGLIPTIN MONOHYDRATE |
211532 |
002 |
ANDA |
DAPAGLIFLOZIN, SAXAGLIPTIN MONOHYDRATE |
TABLET; ORAL |
10MG |
No
|
No
|
2024/01/03
(TA)
|
--
|
LUPIN LTD |
None (Tentative Approval) |